Nyhet

Magle Group launches multicenter trial with pancreatic leakage indicator

Nyhet från Biostock

Publicerad: 24 Mar 11:55

Magle Group has partnered with Heidelberg University Hospital in Germany to launch a study evaluating the effectiveness of SmartPAN in pancreatic surgery.

This post-market study aims to further explore SmartPAN’s ability to detect and prevent pancreatic fluid leakage following surgical procedures.

Lorem ipsum dolor sit amet. Est omnis iusto eos velit nostrum et pariatur quod non. Consequuntur nemo id dolores tempora ut quis quis eum. Porro dolore rem voluptas iste. Consequuntur nemo id dolores tempora ut quis quis eum

•Denna källa har få eller inga artiklar bakom betalvägg

Läs hela artikeln hos Biostock

Börskollen

För dig med koll på börsen

Nyhet

Magle Group launches multicenter trial with pancreatic leakage indicator

Nyhetsbrev